STOCK TITAN

Albemarle Stock Price, News & Analysis

ALB NYSE

Company Description

Albemarle Corporation (NYSE: ALB) is described as a global leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. The company states that it partners with customers to pioneer ways to move, power, connect and protect "with people and planet in mind." A reliable and high-quality global supply of lithium and bromine underpins Albemarle’s ability to deliver advanced solutions to its customers.

According to available information, Albemarle is one of the world’s largest lithium producers and a fully integrated lithium company. Its lithium business includes upstream resources in salt brine deposits and hard rock mines, as well as lithium refining plants. The company also reports that it is a global leader in the production of bromine, which is used in flame retardants and other specialty applications. These activities align with Albemarle’s stated focus on essential elements that support mobility, energy systems, digital connectivity and various health-related uses.

Albemarle is incorporated in Virginia and its common stock trades on the New York Stock Exchange under the symbol ALB. Public disclosures and news releases indicate that the company operates on a global basis and emphasizes a reliable supply of lithium and bromine for its customers. Albemarle also regularly communicates that it is focused on operational excellence, cost and productivity improvements, and portfolio management actions intended to support its long-term strategy.

Business focus and resources

Albemarle’s business is centered on transforming natural resources into lithium and bromine-based products and related solutions. The company highlights lithium as an energy storage material used in batteries, particularly for applications related to mobility and energy. Its bromine activities support flame retardants and other specialty uses tied to connectivity and protection.

Albemarle has described itself as having upstream resources including salt brine deposits and hard rock mines, as well as lithium refining plants in multiple countries. These assets support its role as a fully integrated lithium producer. The company’s communications emphasize that this integrated structure and global footprint are important to providing a reliable and high-quality supply to customers.

Segments and portfolio actions

In its public reporting, Albemarle discusses results and outlook for areas such as Energy Storage, Specialties and Ketjen. Energy Storage relates to lithium-based materials used in energy applications. Specialties includes products such as flame retardants that benefit from bromine chemistry and serve end markets like electrical and electronics applications. Ketjen is described as a business focused on refining catalyst solutions and related technologies.

Albemarle has announced portfolio actions involving Ketjen and its interest in the Eurecat joint venture. The company entered into agreements to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners while retaining an ownership interest, and to sell its 50% stake in the Eurecat joint venture to Axens SA. Albemarle has indicated that these transactions are intended to strengthen its financial flexibility, focus on core businesses and streamline operations, while it continues to own and participate in certain catalyst-related activities through retained interests.

Organizational structure and strategy

Albemarle has described enhancements to its organizational structure intended to align the company for greater agility and efficiency. The company has created integrated functions that bring together resources, manufacturing, capital projects and supply chain, and has highlighted roles focused on enterprise strategy, growth, research and technology, as well as people and workplace transformation. These changes are presented as supporting a market-led enterprise strategy and operational excellence.

In earnings-related disclosures, Albemarle has highlighted cost and productivity improvement programs, capital expenditure adjustments, and portfolio management steps such as the Ketjen and Eurecat transactions. The company has also discussed its approach to managing liquidity, debt levels and free cash flow, indicating an emphasis on financial flexibility alongside its operational and strategic initiatives.

Governance and public company status

Albemarle files reports with the U.S. Securities and Exchange Commission as a public company. Recent Form 8-K filings have covered topics such as quarterly results, material definitive agreements, organizational changes, director and officer changes, and expected goodwill impairment charges related to portfolio transactions. These filings show that Albemarle remains an SEC-reporting issuer with common stock listed on the NYSE.

The company also notes that it regularly posts information on its website, including events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information about its businesses and the markets it serves. Earnings releases are typically accompanied by conference calls and webcasts for analysts and investors.

Role in lithium, bromine and critical minerals

Albemarle’s public descriptions emphasize its role in lithium and bromine as essential elements that support broader trends in mobility, energy, connectivity and health. Lithium is highlighted as a key material for energy storage, while bromine supports flame retardants and other specialty applications. External commentary in the provided data also refers to Albemarle as one of the leading critical mineral companies in the world, with a leading position in lithium and cesium.

Through offtake and prepayment agreements with other companies, Albemarle participates in arrangements that relate to critical minerals such as cesium. These agreements are presented as part of broader efforts in the critical minerals supply chain connected to electrification and decarbonization themes.

FAQs about Albemarle Corporation (ALB)

  • What does Albemarle Corporation do?
    Albemarle states that it transforms essential resources into critical ingredients for mobility, energy, connectivity and health. It emphasizes a reliable global supply of lithium and bromine that supports advanced solutions for customers.
  • How is Albemarle involved in the lithium industry?
    According to the provided information, Albemarle is one of the world’s largest lithium producers and a fully integrated lithium company, with upstream resources and lithium refining plants that support energy storage applications.
  • What role does bromine play in Albemarle’s business?
    Albemarle describes itself as a global leader in the production of bromine, which is used in flame retardants and other applications that contribute to connectivity and protection.
  • On which exchange does Albemarle trade and what is its ticker symbol?
    Albemarle’s common stock trades on the New York Stock Exchange under the ticker symbol ALB.
  • How does Albemarle describe its strategic focus?
    The company highlights a market-led enterprise strategy, operational excellence, cost and productivity improvements, and portfolio management actions aimed at focusing on core businesses and improving financial flexibility.
  • What is Ketjen and how is it related to Albemarle?
    Ketjen is described as a business that develops and markets catalysts and related products for refining and petrochemical applications. It is a subsidiary of Albemarle, and Albemarle has agreed to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners while retaining an ownership interest.
  • What is the Eurecat transaction mentioned in Albemarle’s filings?
    Albemarle, through Ketjen, entered into an agreement for the sale of its 50% interest in the Eurecat joint venture to Axens SA. Albemarle expects to receive cash proceeds from this sale as part of its broader portfolio actions.
  • How does Albemarle communicate financial and operational updates?
    Albemarle issues press releases, files reports with the SEC, and hosts conference calls and webcasts to discuss quarterly and other results. It also notes that it posts information on its website, including investor presentations and non-GAAP reconciliations.

Stock Performance

$157.85
-3.31%
5.41
Last updated: March 20, 2026 at 19:59
+103.43%
Performance 1 year
$19.2B

Albemarle (ALB) stock last traded at $156.70, down 3.31% from the previous close. Over the past 12 months, the stock has gained 103.4%, ranking #105 in 52-week price change. At a market capitalization of $19.2B, ALB is classified as a large-cap stock with approximately 117.8M shares outstanding.

Latest News

Albemarle has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include management, dividends, earnings, earnings date. View all ALB news →

SEC Filings

Albemarle has filed 5 recent SEC filings, including 2 Form 4, 1 Form 144, 1 Form S-3ASR, 1 Form PRE 14A. The most recent filing was submitted on March 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ALB SEC filings →

Insider Radar

Net Sellers
90-Day Summary
0
Shares Bought
25,929
Shares Sold
5
Transactions
Most Recent Transaction
Masters J Kent (Chairman & CEO) sold 996 shares @ $171.82 on Mar 10, 2026

Insider selling at Albemarle over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

$5.1B
Revenue (TTM)
-$510.6M
Net Income (TTM)
$1.3B
Operating Cash Flow

Albemarle generated $5.1B in revenue over the trailing twelve months, retaining a 13.0% gross margin, operating income reached -$367.1M (-7.1% operating margin), and net income was -$510.6M, reflecting a -9.9% net profit margin. Diluted earnings per share stood at $-5.76. The company generated $1.3B in operating cash flow. With a current ratio of 2.23, the balance sheet reflects a strong liquidity position.

Upcoming Events

MAR
30
March 30, 2026 Financial

Tender offers expire

Final expiration date for the cash tender offers (Offer Cap $500M).
APR
01
April 1, 2026 Financial

Quarterly dividend payment

Payable $0.405 per share to holders of record on 2026-03-13; cash payment date.
APR
01
April 1, 2026 Financial

Final settlement expected

Expected final settlement date for accepted tenders and related payments.
APR
01
April 1, 2026 - June 30, 2026 Financial

EBITDA accretion begins

Expected to be accretive to adjusted EBITDA starting Q2 2026 (Apr–Jun 2026)

Albemarle has 4 upcoming scheduled events. The next event, "Tender offers expire", is scheduled for March 30, 2026 (in 8 days). 4 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the ALB stock price.

Short Interest History

Last 12 Months

Short interest in Albemarle (ALB) currently stands at 9.1 million shares, down 5.8% from the previous reporting period, representing 7.8% of the float. Over the past 12 months, short interest has decreased by 29.6%.

Days to Cover History

Last 12 Months

Days to cover for Albemarle (ALB) currently stands at 2.2 days, down 20% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 63.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.2 to 6.1 days.

ALB Company Profile & Sector Positioning

Albemarle (ALB) operates in the Specialty Chemicals industry within the broader Plastic Materials, Synth Resins & Nonvulcan Elastomers sector and is listed on the NYSE. Among dividend-paying stocks, ALB ranks #1,292 by dividend yield. In monthly performance, the stock ranks #1,507 among all tracked companies.

Investors comparing ALB often look at related companies in the same sector, including Eastman Chem Co (EMN), Newmarket (NEU), Axalta Coating Sys Ltd (AXTA), Element Solutions Inc (ESI), and Sasol (SSL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ALB's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Albemarle (ALB)?

The current stock price of Albemarle (ALB) is $156.7 as of March 20, 2026.

What is the market cap of Albemarle (ALB)?

The market cap of Albemarle (ALB) is approximately 19.2B. Learn more about what market capitalization means .

What is the revenue (TTM) of Albemarle (ALB) stock?

The trailing twelve months (TTM) revenue of Albemarle (ALB) is $5.1B.

What is the net income of Albemarle (ALB)?

The trailing twelve months (TTM) net income of Albemarle (ALB) is -$510.6M.

What is the earnings per share (EPS) of Albemarle (ALB)?

The diluted earnings per share (EPS) of Albemarle (ALB) is $-5.76 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Albemarle (ALB)?

The operating cash flow of Albemarle (ALB) is $1.3B. Learn about cash flow.

What is the profit margin of Albemarle (ALB)?

The net profit margin of Albemarle (ALB) is -9.9%. Learn about profit margins.

What is the operating margin of Albemarle (ALB)?

The operating profit margin of Albemarle (ALB) is -7.1%. Learn about operating margins.

What is the gross margin of Albemarle (ALB)?

The gross profit margin of Albemarle (ALB) is 13.0%. Learn about gross margins.

What is the current ratio of Albemarle (ALB)?

The current ratio of Albemarle (ALB) is 2.23, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Albemarle (ALB)?

The gross profit of Albemarle (ALB) is $668.7M on a trailing twelve months (TTM) basis.

What is the operating income of Albemarle (ALB)?

The operating income of Albemarle (ALB) is -$367.1M. Learn about operating income.

What is Albemarle Corporation’s core business?

Albemarle Corporation focuses on transforming essential resources into critical ingredients for mobility, energy, connectivity and health. It emphasizes a reliable global supply of lithium and bromine that supports advanced solutions for its customers.

How is Albemarle positioned in the lithium market?

The available information describes Albemarle as one of the world’s largest lithium producers and a fully integrated lithium company, with upstream resources and lithium refining plants that support energy storage applications.

What role does bromine play in Albemarle’s portfolio?

Albemarle states that it is a global leader in bromine production. Bromine is used in flame retardants and other applications that contribute to connectivity and protection, aligning with the company’s focus on essential elements.

Where is Albemarle’s stock listed and what is its ticker?

Albemarle’s common stock is listed on the New York Stock Exchange under the ticker symbol ALB.

How does Albemarle describe its overall strategy?

Albemarle highlights a market-led enterprise strategy focused on operational excellence, cost and productivity improvements, and portfolio management actions that support its core businesses and financial flexibility.

What is the relationship between Albemarle and Ketjen?

Ketjen is a subsidiary of Albemarle that develops, manufactures and markets catalysts and related products. Albemarle has agreed to sell a controlling stake in Ketjen’s refining catalyst solutions business to an affiliate of KPS Capital Partners while retaining an ownership interest.

What is the Eurecat joint venture and what has Albemarle announced about it?

Eurecat is a joint venture in which Ketjen held a 50% interest. Albemarle has disclosed that Ketjen entered into an agreement for the sale of this interest to Axens SA, with Albemarle expecting to receive cash proceeds as part of its broader portfolio actions.

How does Albemarle share financial results with investors?

Albemarle issues earnings press releases, files reports such as Form 8-K with the SEC, and hosts conference calls and webcasts to discuss its quarterly and other results. It also posts related information, including investor presentations and non-GAAP reconciliations, on its website.